The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and ...

Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on preventing heart failure by reducing myocardial damage in acute ST-elevation myocardial infarction (STEMI) through ...

A new study reveals that heart attack survivors could greatly reduce their risk of a second event by starting combination ...

A study presented at ACC 2025 found that colchicine use in diabetic patients without CAD significantly reduced 3-year ...

Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.

Not everyone is sold on the benefits of early ezetimibe use, especially given the modest effect seen in IMPROVE-IT.

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered, potentially paving the way for innovative treatments that align with the natural ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by ...

Adverse cardiovascular outcomes can be predicted in patients with coronary artery disease with a risk score that includes mental stress outcomes.